BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7413468)

  • 1. [Blood platelet function before and after dipyridamole in patients on chronic hemodialysis].
    Twardowski Z; Janicka L; Dmoszyńska A; Gutka A; Pluta A; Kowalewski J
    Pol Arch Med Wewn; 1980 Apr; 63(4):383-91. PubMed ID: 7413468
    [No Abstract]   [Full Text] [Related]  

  • 2. [The efficacy of kurantil and its effect on thrombocytic hemostasis in patients with chronic glomerulonephritis].
    Kolesnyk MO; Lapchyns'ka II; Bielyts'ka HO
    Lik Sprava; 1994; (9-12):145-8. PubMed ID: 7604556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of persantin on selected platelet functions in myocardial infarct].
    Markiewicz M; Kowalewski J; Florkiewicz H; Pluta A; Koziara Z; Szponar M; Dmosyńska A
    Pol Tyg Lek; 1980 Sep; 35(35):1343-5. PubMed ID: 7433215
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of dipyridamole on coagulation status in stenocardia].
    Ficović P; Gjurić Z; Grgić Z
    Bilt Hematol Transfuz; 1978; 6(2):49-55. PubMed ID: 754694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-thromboembolic therapy and effects of dipyridamole on platelet function in patients with heart valve prostheses (authors transl)].
    Tokumo M; Doko S; Ono Y; Takabatake T; Noguchi A; Omoto T; Teramoto S
    Kyobu Geka; 1978; 31(1):19-22. PubMed ID: 628105
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet function studies in coronary artery disease. X. Effect of dipyridamole.
    Mehta J; Mehta P; Pepine CJ; Conti CR
    Am J Cardiol; 1981 May; 47(5):1111-4. PubMed ID: 7013461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of platelet activity in patients with prosthetic heart valves.
    Bran M; Capel P; Messin R
    Rev Med Brux; 1980 Feb; 1(2):71-5. PubMed ID: 7403713
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rsearch into the inhibitory effect of dipyridamole on the adhesion and clumping of blood platelets "in vitro" and "in vivo"].
    Griguer P; Brochier M; Raynaud R
    Ann Cardiol Angeiol (Paris); 1975; 24(1 SUPPL):1-36. PubMed ID: 1096747
    [No Abstract]   [Full Text] [Related]  

  • 9. [Summary: Drugs affecting platelet behaviour; experimental and clinical data (author's transl)].
    Bouvier CA
    Ther Umsch; 1974 Feb; 31(2):84-8. PubMed ID: 4612856
    [No Abstract]   [Full Text] [Related]  

  • 10. [Secondary prevention of coronary disease with platelet aggregation inhibiting drugs. Preliminary report].
    Caruzzo C; Belli R; Biasci R; Gaschino G; Bruna C
    Minerva Cardioangiol; 1979 Jun; 27(6):367-72. PubMed ID: 38413
    [No Abstract]   [Full Text] [Related]  

  • 11. [Disorders of haemostasis in patients undergoing maintenance haemodialysis, with special reference to recurrent arteriovenous fistula thrombosis. Effects of dipyridamole (author's transl)].
    Jacques C; Drueke T; Nedellec J; Kremp O; Gazengel C
    Pathol Biol (Paris); 1976 Dec; 24 Suppl():27-32. PubMed ID: 827731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of vitamin E on platelet function and anemia in patients on long-term hemodialysis].
    Janicka L; Dmoszyńska A; Ksiazek A; Kozioł M
    Pol Tyg Lek; 1988 Nov; 43(48):1557-8. PubMed ID: 3255907
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pregnancy, heart valve prostheses and anti-platelet aggregation treatment].
    Ben Ismail M; Ghariani M; Jais JM
    Nouv Presse Med; 1975 Mar; 4(10):746 (2). PubMed ID: 1129046
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhanced in vitro platelet aggregation in hemodialysis patients.
    Viener A; Aviram M; Better OS; Brook JG
    Nephron; 1986; 43(2):139-43. PubMed ID: 3713942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of latamoxef on platelet aggregation in hemodialysis and continuous ambulatory peritoneal dialysis (CAPD) patients].
    Inoue T; Sakaguchi K; Yoshida K; Imai T; Kajimoto Y; Shirai D
    Nihon Jinzo Gakkai Shi; 1986 Feb; 28(2):177-83. PubMed ID: 3735768
    [No Abstract]   [Full Text] [Related]  

  • 16. [Aggregation inhibitors. The inhibition of platelet function by means of chemical substances].
    Reuter H
    Thromb Diath Haemorrh Suppl; 1973; 55():221-40. PubMed ID: 4373867
    [No Abstract]   [Full Text] [Related]  

  • 17. Erythropoietin and spontaneous platelet aggregation in haemodialysis patients.
    Taylor JE; Henderson IS; Stewart WK; Belch JJ
    Lancet; 1991 Nov; 338(8779):1361-2. PubMed ID: 1682739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet function in patients on long term peritoneal dialysis.
    Lindsay RM; Friesen M; Koens F; Linton AL; Oreopoulos D; de Veber G
    Clin Nephrol; 1976 Aug; 6(2):335-9. PubMed ID: 954241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet function in dialyzed and non-dialyzed patients with chronic renal failure.
    Lindsay RM; Moorthy AV; Koens F; Linton AL
    Clin Nephrol; 1975 Aug; 4(2):52-7. PubMed ID: 1157351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of platelet aggregation and adherence to prosthetic vascular grafts by aspirin and dipyridamole.
    Oblath RW; Buckley FO; Green RM; Schwartz SI; DeWeese JA
    Surgery; 1978 Jul; 84(1):37-44. PubMed ID: 149385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.